Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C19 | P33261 | 1/20 | 0.71 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.45 |
| ▸ | LMNA | P02545 | 4/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.45 |
| ▸ | MAPT | P10636 | 2/20 | 0.45 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.45 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.45 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.36 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.36 |
| ▸ | SRC | P12931 | 1/20 | 0.36 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.35 |
| ▸ | CTSD | P07339 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9577255 | 0.84 | CYP2C19 (0.73) | CYP2C19ALDH1A1LMNASMN1; SMN2KDM4E | |
| SCHEMBL5371218 | 0.83 | CYP2C19 (0.79) | CYP2C19ALDH1A1LMNASMN1; SMN2KDM4E | |
| SCHEMBL1458050 | 0.83 | CYP2C19 (1.00) | CYP2C19ALDH1A1LMNASMN1; SMN2KDM4E | |
| SCHEMBL666893 | 0.83 | CYP2C19 (1.00) | CYP2C19ALDH1A1LMNASMN1; SMN2KDM4E | |
| SCHEMBL1458057 | 0.83 | CYP2C19 (1.00) | CYP2C19ALDH1A1LMNASMN1; SMN2KDM4E | |
| SCHEMBL1458161 | 0.81 | CYP2C19 (0.96) | CYP2C19ALDH1A1LMNASMN1; SMN2KDM4E | |
| SCHEMBL6967261 | 0.81 | CYP2C19 (0.76) | CYP2C19ALDH1A1LMNASMN1; SMN2KDM4E | |
| SCHEMBL1457969 | 0.81 | CYP2C19 (0.96) | CYP2C19ALDH1A1LMNASMN1; SMN2KDM4E | |
| SCHEMBL10959538 | 0.81 | CYP2C19 (0.96) | CYP2C19ALDH1A1LMNASMN1; SMN2KDM4E | |
| SCHEMBL28501622 | 0.81 | CYP2C19 (0.47) | CYP2C19ALDH1A1SMN1; SMN2KDM4EMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 50 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2655478-B1 | PHOTOACTIVE POLYMER MATERIALS | ROLIC AG (CH) | 2017-06-14 | — | — | EP | claimed |
| EP-0860455-B1 | Photocrosslinkable polymers | ROLIC AG (CH) | 2008-06-04 | — | — | EP | claimed |
| EP-0763552-B1 | Curable, photoactive polymeric materials | ROLIC AG (CH) | 2001-09-19 | — | — | EP | claimed |
| EP-0860455-A2 | Photocrosslinkable polymers | Rolic AG (CH) | 1998-08-26 | — | — | EP | claimed |
| EP-0763552-A2 | Curable, photoactive polymeric materials | Rolic AG (CH) | 1997-03-19 | — | — | EP | claimed |
| EP-0324480-B1 | Photopolymerizable compositions and elements for refractive index imaging | DU PONT (US) | 1994-04-13 | — | — | EP | claimed |
| US-12044872-B2 | Method for generating alignment on top of a liquid crystal polymer material | Rolic Technologies AG (CH) | 2024-07-23 | — | — | US | disclosed |
| US-12012382-B2 | Polymerizable liquid crystal having a carbazole core | Rolic Technologies AG (CH) | 2024-06-18 | — | — | US | disclosed |
| US-12006463-B2 | Polymerizable liquid crystal having a quinoxaline-hydrazone core | Rolic Technologies AG (CH) | 2024-06-11 | — | — | US | disclosed |
| US-11952524-B2 | Compositions of polymerizable liquid crystals | Rolic Technologies AG (CH) | 2024-04-09 | — | — | US | disclosed |
| EP-3990568-B1 | NEW POLYMERIZABLE LIQUID CRYSTAL HAVING A QUINOXALINE-HYDRAZONE CORE | ROLIC TECH AG (CH) | 2023-11-15 | — | — | EP | disclosed |
| US-11702595-B2 | Polymerizable liquid crystal | Rolic Technologies AG (CH) | 2023-07-18 | — | — | US | disclosed |
| EP-3126883-B1 | OPTICAL DEVICES WITH PATTERNED ANISOTROPY INCORPORATING PARALLAX OPTIC | ROLIC TECH AG (CH) | 2023-07-12 | — | — | EP | disclosed |
| EP-0860455-A2 | Photocrosslinkable polymers | Rolic AG (CH) | 1998-08-26 | — | — | EP | disclosed |
| EP-0763552-A2 | Curable, photoactive polymeric materials | Rolic AG (CH) | 1997-03-19 | — | — | EP | disclosed |
| EP-0572900-A2 | Coating and its use in a process for preparing multilayer coatings | Herberts Gesellschaft mit beschränkter Haftung (DE) | 1993-12-08 | — | — | EP | disclosed |
| EP-0269288-B1 | INTRAOCULAR LENSES | KINGSTON TECHNOLOGIES, INC. (US) | 1992-02-19 | — | — | EP | disclosed |
| EP-0269288-A1 | Intraocular lenses | KINGSTON TECHNOLOGIES, INC. (US) | 1988-06-01 | — | — | EP | disclosed |
| US-4731079-A | Intraocular lenses | KINGSTON TECHNOLOGIES, INC. (US) | 1988-03-15 | — | — | US | disclosed |
| EP-0181161-A2 | Oral hygiene products | Stafford-Miller Ltd. (GB) | 1986-05-14 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12012382-B2 | Polymerizable liquid crystal having a carbazole core | FZD7, CCL11, SGK2 | CYP2C19 148/4885ALDH1A1 2627/4885LMNA 2536/4885 |
| US-12006463-B2 | Polymerizable liquid crystal having a quinoxaline-hydrazone core | AQP1, AQP4, HCN1 | CYP2C19 1068/4885ALDH1A1 1459/4885LMNA 732/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.